Your browser doesn't support javascript.
loading
Quality of Life in a Cohort of 1078 Women Diagnosed with Breast Cancer in Spain: 7-Year Follow-Up Results in the MCC-Spain Study.
Alonso-Molero, Jéssica; Dierssen-Sotos, Trinidad; Gomez-Acebo, Ines; Fernandez de Larrea Baz, Nerea; Guevara, Marcela; Amiano, Pilar; Castaño-Vinyals, Gemma; Fernandez-Villa, Tania; Moreno, Victor; Bayo, Juan; Molina-Barceloa, Ana; Fernández-Ortíz, María; Suarez-Calleja, Claudia; Marcos-Gragera, Rafael; Castells, Xavier; Gil-Majuelo, Leire; Ardanaz, Eva; Pérez-Gómez, Beatriz; Kogevinas, Manolis; Pollán, Marina; Llorca, Javier.
Afiliação
  • Alonso-Molero J; Department of Preventive Medicine and Public Health, University of Cantabria-IDIVAL, 39011 Santander, Spain.
  • Dierssen-Sotos T; CIBER Epidemiologia y Salud Pública (CIBERESP), 28029 Madrid, Spain.
  • Gomez-Acebo I; Department of Preventive Medicine and Public Health, University of Cantabria-IDIVAL, 39011 Santander, Spain.
  • Fernandez de Larrea Baz N; CIBER Epidemiologia y Salud Pública (CIBERESP), 28029 Madrid, Spain.
  • Guevara M; Department of Preventive Medicine and Public Health, University of Cantabria-IDIVAL, 39011 Santander, Spain.
  • Amiano P; CIBER Epidemiologia y Salud Pública (CIBERESP), 28029 Madrid, Spain.
  • Castaño-Vinyals G; CIBER Epidemiologia y Salud Pública (CIBERESP), 28029 Madrid, Spain.
  • Fernandez-Villa T; Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Carlos III Institute of Health, 28029 Madrid, Spain.
  • Moreno V; CIBER Epidemiologia y Salud Pública (CIBERESP), 28029 Madrid, Spain.
  • Bayo J; Navarra Public Health Institute, 31003 Pamplona, Spain.
  • Molina-Barceloa A; IdiSNA (Navarra Institute for Health Research), 31008 Pamplona, Spain.
  • Fernández-Ortíz M; CIBER Epidemiologia y Salud Pública (CIBERESP), 28029 Madrid, Spain.
  • Suarez-Calleja C; Public Health Division of Gipuzkoa, Biodonostia Research Institute, 20014 San Sebastian, Spain.
  • Marcos-Gragera R; CIBER Epidemiologia y Salud Pública (CIBERESP), 28029 Madrid, Spain.
  • Castells X; ISGlobal, 08036 Barcelona, Spain.
  • Gil-Majuelo L; Epidemiology and Evaluation Department, IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain.
  • Ardanaz E; Department of Experimental and Health Sciences, 08002 Barcelona, Spain.
  • Pérez-Gómez B; Grupo de Investigación en Interacciones Gen-Ambiente y Salud (GIIGAS), Instituto de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain.
  • Kogevinas M; CIBER Epidemiologia y Salud Pública (CIBERESP), 28029 Madrid, Spain.
  • Pollán M; Cancer Prevention and Control Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, 08901 Barcelona, Spain.
  • Llorca J; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, 08036 Barcelona, Spain.
Article em En | MEDLINE | ID: mdl-33202919
Breast cancer is the most frequent cause of tumors and net survival is increasing. Achieving a higher survival probability reinforces the importance of studying health-related quality of life (HR-QoL). The main aim of this work is to test the relationship between different sociodemographic, clinical and tumor-intrinsic characteristics, and treatment received with HR-QoL measured using SF-12 and the FACT/NCCN (National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy) Breast Symptom Index (FBSI). Women with breast cancer recruited between 2008 and 2013 and followed-up until 2017-2018 in a prospective cohort answered two HR-QoL surveys: the SF-12 and FBSI. The scores obtained were related to woman and tumor characteristics using linear regression models. The telephone survey was answered by 1078 women out of 1685 with medical record follow-up (64%). Increases in all three HR-QoL scores were associated with higher educational level. The score differences between women with university qualifications and women with no schooling were 5.43 for PCS-12, 6.13 for MCS-12 and 4.29 for FBSI. Histological grade at diagnosis and recurrence in the follow-up displayed a significant association with mental and physical HR-QoL, respectively. First-line treatment received was not associated with HR-QoL scores. On the other hand, most tumor characteristics were not associated with HR-QoL. As breast cancer survival is improving, further studies are needed to ascertain if these differences still hold in the long run.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias da Mama Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Região como assunto: Europa Idioma: En Revista: Int J Environ Res Public Health Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias da Mama Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Região como assunto: Europa Idioma: En Revista: Int J Environ Res Public Health Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha